Skip to search formSkip to main contentSkip to account menu

AIDSVAX B-E

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

AIDS Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity
Induction of protective antibodies is a critical goal of HIV-1 vaccine development. One strategy is to induce non-neutralizing… 
2015
2015
Response to Letter to the Editor
The Letter to the Editor commenting on our recent paper, provides a concern regarding the statement “The immune-correlate… 
2015
2015
Identification of Immunodominant CD4-Restricted Epitopes Co-Located with Antibody Binding Sites in Individuals Vaccinated with ALVAC-HIV and AIDSVAX B/E
We performed fine epitope mapping of the CD4+ responses in the ALVAC-HIV-AIDSVAX B/E prime-boost regimen in the Thai Phase III… 
2014
2014
RV306, an Evaluation of a 48 Week ALVAC-HIV AIDSVAX B/E Vaccination Regimen in Thailand: Participation Rates for Optional Specimen Collections
Highly Cited
2013
Highly Cited
2013
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
BACKGROUND The Thai Phase III Trial of ALVAC-HIV and AIDSVAX B/E showed an estimated vaccine efficacy (VE) of 31% to prevent… 
2010
2010
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
2009
2009
Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand
Background:We investigated effects of vaccination with AIDSVAX B/E HIV-1 candidate vaccine on blood and seminal plasma HIV-1 RNA… 
2009
2009
HIV vaccine trial results--an opening for further research.
HIV-AIDS has emerged as an enormous, worldwide public health problem over the past 25 years. An estimated 33 million persons are… 
2004
2004
Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand
Objectives: To describe recruitment, screening and baseline characteristics of injection drug users (IDU) participating in a… 
2003
2003
AIDSVAX flop leaves vaccine field unscathed
HIV vaccine researchers have known for years that VaxGen's AIDSVAX, and others like it, have little chance of inducing antibodies… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)